CIK 0001888886 · Large accelerated filer
Structure Therapeutics Inc.
Sign in to watch- Ticker
- GPCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981480821
- Phone
- (650) 457-1978
- Business address
- 601 GATEWAY BLVD SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- ShouTi Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-21 | Coll Crespo Blas CHIEF MEDICAL OFFICER | Conversion 10b5-1 | −12,024 | 258,228 | ||
| 2026-09-21 | Coll Crespo Blas CHIEF MEDICAL OFFICER | Conversion · American Depositary Shares 10b5-1 | +4,008 | 5,165 | ||
| 2026-09-21 | Coll Crespo Blas CHIEF MEDICAL OFFICER | Sale · American Depositary Shares 10b5-1 | −4,008 | $36.15 | $145K | 1,157 |
| 2026-09-18 | Coll Crespo Blas CHIEF MEDICAL OFFICER | Shares withheld for taxes 10b5-1 | −10,626 | $11.67 | $124K | 270,252 |
| 2026-09-01 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +17,817 | $0.34 | $6K | 246,777 |
| 2026-09-01 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Conversion 10b5-1 | −17,817 | 228,960 | ||
| 2026-09-01 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Option exercise · Share Option (right to buy) 10b5-1 | −17,817 | 125,081 | ||
| 2026-09-01 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Conversion · American Depositary Shares 10b5-1 | +5,939 | 5,939 | ||
| 2026-09-01 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale · American Depositary Shares 10b5-1 | −1,300 | $45.86 | $60K | 4,639 |
| 2026-09-01 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale · American Depositary Shares 10b5-1 | −4,539 | $47.20 | $214K | 100 |
| 2026-09-01 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale · American Depositary Shares 10b5-1 | −100 | $47.83 | $5K | 0 |
| 2026-08-18 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Option exercise 10b5-1 | +11,817 | $0.34 | $4K | 240,777 |
| 2026-08-18 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Conversion 10b5-1 | −11,817 | 228,960 | ||
| 2026-08-18 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Option exercise · Share Option (right to buy) 10b5-1 | −11,817 | 142,898 | ||
| 2026-08-18 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Conversion · American Depositary Shares 10b5-1 | +3,939 | 3,939 | ||
| 2026-08-18 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale · American Depositary Shares 10b5-1 | −3,020 | $53.13 | $160K | 919 |
| 2026-08-18 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale · American Depositary Shares 10b5-1 | −519 | $54.20 | $28K | 400 |
| 2026-08-18 | Lin Xichen CHIEF SCIENTIFIC OFFICER | Sale · American Depositary Shares 10b5-1 | −400 | $55.05 | $22K | 0 |
| 2026-08-06 | Berrios John Joseph Chief Commercial Officer | Grant or award | +140,766 | 140,766 | ||
| 2026-08-06 | Berrios John Joseph Chief Commercial Officer | Grant or award · Share option (right to buy) | +174,612 | 174,612 |
Page 1 of 12 · 233 trades